Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence.

BMC public health - 9 Nov 2010

Marteau Theresa M, Munafò Marcus R, Aveyard Paul, Hill Chloe, Whitwell Sophia, Willis Thomas A, Crockett Rachel A, Hollands Gareth J, Johnstone Elaine C, Wright Alison J, Prevost A Toby, Armstrong David, Sutton Stephen, Kinmonth Ann Louise

Abstract excerpt

BACKGROUND: The behavioural impact of pharmacogenomics is untested; informing smokers of genetic test results for responsiveness to smoking cessation medication may increase adherence to this medication. The objective of this trial is to estimate the impact upon adherence to nicotine replacement therapy (NRT) of informing smokers that their oral dose of NRT has been tailored to a DNA analysis. Hypotheses to be...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Communication
Share to England

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Targeted Therapy

Share to Nicotine

Share to Patient Compliance

Share to Receptors, Opioid, mu

Share to Research Design

Share to Smoking Cessation

Source

Open in PubMed Open full text

Identifiers

PMID: 21062464
DOI: 10.1186/1471-2458-10-680
PMCID: PMC2996370

Genes

NHS
OPRM1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence.PMID 21062464Read ↗

Effect on adherence to nicotine replacement therapy of informing smokers their dose is determined by their genotype: a randomised controlled trial.Semantic proximity Read ↗

Factors influencing the impact of pharmacogenomic prescribing on adherence to nicotine replacement therapy: A qualitative study of participants from a randomized controlled trial.Semantic proximity Read ↗

Smoking cessation treatment: pharmacogenetic assessment.Semantic proximity Read ↗

The association of rs1051730 genotype on adherence to and consumption of prescribed nicotine replacement therapy dose during a smoking cessation attempt.Semantic proximity Read ↗

Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials.Semantic proximity Read ↗

Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers.Semantic proximity Read ↗

The impact of learning of a genetic predisposition to nicotine dependence: an analogue study.Semantic proximity Read ↗

Lack of association of OPRM1 genotype and smoking cessation.Semantic proximity Read ↗

Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial.Semantic proximity Read ↗

The clinical usefulness of knowing CHRNA5 polymorphism genotype: paving the way for personalized therapy.Semantic proximity Read ↗

Effect of communicating DNA based risk assessments for Crohn's disease on smoking cessation: randomised controlled trial.Semantic proximity Read ↗

Nicotine abstinence genotyping: assessing the impact on smoking cessation clinical trials.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.